3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
US8846024B2 · kind B2 · utility
0Cited by
24References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 10, 2013 |
| Grant date | Sep 30, 2014 |
| Priority date | — |
| Expiry date | Oct 10, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D231/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An improved thrombopoietin mimetic, the bis-(monoethanolamine) salt of 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.